Literature DB >> 14609712

Inflammatory bowel disease and the eye.

Faruque D Ghanchi1, Bjorn J Rembacken.   

Abstract

Inflammatory bowel disease includes Crohn's disease and ulcerative colitis, and is characterized by chronic inflammation of the intestines. The advances in understanding of the inflammatory process have resulted in improved treatment of inflammatory bowel disease. The systemic complications of inflammatory bowel disease involve many organs, eyes included. The ophthalmic complications are usually of inflammatory origin. Some of these complications, like scleritis, may reflect overall disease activity. Treatment of intestinal inflammation-either medical or surgical-usually helps resolution of ophthalmic complications. This review describes recent developments in the diagnosis and management of the inflammatory bowel disease and its ophthalmic complications.

Entities:  

Mesh:

Year:  2003        PMID: 14609712     DOI: 10.1016/j.survophthal.2003.08.004

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  20 in total

1.  [Unilateral visual impairment in the presence of retinal hemorrhages in a 35-year old female patient].

Authors:  T U Krohne; C Inhetvin-Hutter; F G Holz
Journal:  Ophthalmologe       Date:  2005-06       Impact factor: 1.059

Review 2.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

3.  Subretinal fibrosis and uveitis syndrome associated with ulcerative colitis.

Authors:  Graciana Fuentes-Páez; Hernán Martínez-Osorio; José M Herreras; Margarita Calonge
Journal:  Int J Colorectal Dis       Date:  2006-05-24       Impact factor: 2.571

4.  Choroidal neovascularization in a patient with ulcerative colitis.

Authors:  Kenji Ishihara; Akitaka Tsujikawa; Yuko Yodoi; Takanori Kameda; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2008-12-17       Impact factor: 2.447

Review 5.  Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease.

Authors:  Jurij Hanzel; Christopher Ma; Niels Vande Casteele; Reena Khanna; Vipul Jairath; Brian G Feagan
Journal:  Drugs       Date:  2021-01-05       Impact factor: 9.546

6.  Optic Neuritis Associated or Not with TNF Antagonists in Patients with Inflammatory Bowel Disease.

Authors:  Benjamin Alexandre; Yves Vandermeeren; Olivier Dewit; Tom Moreels; Nanne de Boer; Anjan Dhar; Chris Ziady; Ariella Bar-Gil Shitrit; Flavio Steinwurz; Njegica Jojic; Giuseppe Costantino; Benoit Bihin; Jean-François Rahier; Konstantinos H Katsanos
Journal:  J Crohns Colitis       Date:  2016-01-12       Impact factor: 9.071

7.  Concurrent macular oedema and optic neuritis in Crohn's disease with varied response to steroids.

Authors:  Adeela Malik; Rosina H Zakri; Zenobia Sheikh; Zaid Shalchi; Rashid Zia; David J Schultz
Journal:  BMJ Case Rep       Date:  2010-04-05

8.  Retinal vasculitis: a novel paradoxical effect of anti-TNFα?

Authors:  Kaouther Ben Abdelghani; Maroua Slouma; Wady Ben Jalel; Leith Zakraoui
Journal:  BMJ Case Rep       Date:  2014-08-20

9.  The prevalence of ocular involvement in patients with inflammatory bowel disease.

Authors:  Safiye Yilmaz; Ebru Aydemir; Ahmet Maden; Belkis Unsal
Journal:  Int J Colorectal Dis       Date:  2007-01-30       Impact factor: 2.571

10.  Ocular dysfunction in a mouse model of chronic gut inflammation.

Authors:  Megan N Watts; Wendy Leskova; Patsy R Carter; Songlin Zhang; Melissa Kosloski-Davidson; Matthew B Grisham; Norman R Harris
Journal:  Inflamm Bowel Dis       Date:  2013-09       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.